Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dart

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Circulation|May 1, 1992
Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrineG Eisenhofer, M D Esler, I T Meredith, et al.
Oncogene|September 12, 2006
Prohibitin, a protein downregulated by androgens, represses androgen receptor activityS C Gamble, D Chotai, M Odontiadis, et al.
Diabetes Care|November 15, 2007
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Henry R Black, Barry Davis, Joshua Barzilay, et al.
Journal of Hypertension|May 21, 2014
Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHATEfrain Reisin, John W Graves, José-Miguel Yamal, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?Richard H Grimm, Barry R Davis, Linda B Piller, et al.
Hypertension (Dallas, Tex. : 1979)|July 23, 2016
Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart AssociationFernando Elijovich, Myron H Weinberger, Cheryl A M Anderson, et al.
Cardiovascular Digital Health Journal|March 3, 2023
Validating cuffless continuous blood pressure monitoring devicesJiun-Ruey Hu, Gabrielle Martin, Sanjna Iyengar, et al.
Journal of General Internal Medicine|July 9, 2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHATLinda B Piller, Lara M Simpson, Sarah Baraniuk, et al.
Diabetes Care|August 29, 2015
Feasibility of Outpatient 24-Hour Closed-Loop Insulin DeliveryMartin I de Bock, Anirban Roy, Matthew N Cooper, et al.
American Heart Journal|December 1, 2012
Cardiovascular risk assessment: addition of CKD and race to the Framingham equationPaul E Drawz, Sarah Baraniuk, Barry R Davis, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Circulation|May 1, 1992
Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrineG Eisenhofer, M D Esler, I T Meredith, et al.
Oncogene|September 12, 2006
Prohibitin, a protein downregulated by androgens, represses androgen receptor activityS C Gamble, D Chotai, M Odontiadis, et al.
Diabetes Care|November 15, 2007
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Henry R Black, Barry Davis, Joshua Barzilay, et al.
Journal of Hypertension|May 21, 2014
Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHATEfrain Reisin, John W Graves, José-Miguel Yamal, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?Richard H Grimm, Barry R Davis, Linda B Piller, et al.
Hypertension (Dallas, Tex. : 1979)|July 23, 2016
Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart AssociationFernando Elijovich, Myron H Weinberger, Cheryl A M Anderson, et al.
Cardiovascular Digital Health Journal|March 3, 2023
Validating cuffless continuous blood pressure monitoring devicesJiun-Ruey Hu, Gabrielle Martin, Sanjna Iyengar, et al.
Journal of General Internal Medicine|July 9, 2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHATLinda B Piller, Lara M Simpson, Sarah Baraniuk, et al.
Diabetes Care|August 29, 2015
Feasibility of Outpatient 24-Hour Closed-Loop Insulin DeliveryMartin I de Bock, Anirban Roy, Matthew N Cooper, et al.
American Heart Journal|December 1, 2012
Cardiovascular risk assessment: addition of CKD and race to the Framingham equationPaul E Drawz, Sarah Baraniuk, Barry R Davis, et al.
Pageof 11